Actavis (ACT) Price Target Raised to $280 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Filing Shows Allergan (AGN), Actavis (ACT) Talks Continue
November 6, 2014 9:23 AM ESTAn SEC filing by Allergan (NYSE: AGN) shows takeover talks with a third party believed to be Actavis Plc (NYSE: ACT) have continued. The text from the filing is below.
"Notwithstanding the foregoing, we have been approached by... More
Valeant Pharma (VRX) on Watch on Actavis/Allergan Headlines
November 6, 2014 9:21 AM ESTValeant Pharma (NYSE: VRX) on watch as Actavis Plc (NYSE: ACT) is said to be in advanced takeover talks with Allergan (NYSE: AGN), according to Bloomberg. Valeant is pursing its own hostile bid for AGN.
... MoreActavis Plc (ACT) said to be in active takeover talks with Allergan (AGN) - Bloomberg
November 6, 2014 9:19 AM ESTActavis Plc (NYSE: ACT) said to be in active takeover talks with Allergan (NYSE: AGN) according to Bloomberg.
... MoreActavis Plc (ACT) Tops Q3 EPS by 9c
November 5, 2014 6:31 AM ESTActavis Plc (NYSE: ACT) reported Q3 EPS of $3.19, $0.09 better than the analyst estimate of $3.10. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.63 billion.
Raises H214 adjusted EPS outlook to $6.60 - $6.70.
For earnings history and earnings-related data on Actavis Plc (ACT) click here.
... More